DECARD
Current finance flows are insufficient to achieve a net-zero emission and resilient economy by 2050 (UNFCCC, 2021). DECARD and Africa Investor partner up to mobilise, deploy and accelerate climate capital. At COP27 their contribution is to bridge the climate finance gap and address Scope 3 emissions by directing investment towards bankable nature-based projects at scale.
Climate Capital Technologies, a new partnership between DECARD and Africa Investor, aims to create viable business models to mobilise and especially deploy investment in nature-based and sustainable projects. Project identification and vetting capabilities of Africa Investor, coupled with DECARD's expertise in Web3 infrastructure and community-focused economic governance, will enable robust investment and capital facilitation of ESG projects at scale.
The objective is to build novel decentralised economic infrastructure utilising Web3 technology to accurately identify Scope 3 emissions in the value chains and accelerate capital flows into net-zero projects, decarbonising infrastructure and scaling up sustainable solutions.
Delivering on Paris Agreements' targets means achieving significant scale and quality of public and private investments in the near term. Today, cumbersome supply chains, high transaction fees, and indirect project funding cause bottlenecks to effectively financing adaptation and resilience projects globally. Innovative tools and financial mechanisms are needed to improve countries' access to climate finance and catalyse investments in climate action.
The UN Climate Conference, COP27, takes place in Sharm el-Sheikh, Egypt, from 6 -18 November. Mitigation, adaptation and climate finance are the three significant objectives driving goal-setting this year. Governments, businesses, NGOs and civil society groups convene to negotiate and plan the implementation of pledges regarding net-zero commitments, climate finance and forest protection.
About
Africa Investor (AI), an institutional investment holding platform, is a principal investor in strategic infrastructure assets in Africa and an advisor to institutional investors around the globe. AI bridges pools of capital from sovereign wealth and pension funds, family offices and long-term investors with vetted infrastructure, private equity and technology investment opportunities.
DECARD is a Web3 technology and banking powerhouse with cutting-edge expertise in scalable DLT solutions, financial instrument and product innovation, governance and distributed products and services.
###
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221109005536/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
INNIO Secures Largest Order in Company History with VoltaGrid Delivering Power Generation for One of the World’s Largest Data Centers21.10.2025 09:01:00 CEST | Press release
INNIO to supply 2.3 gigawatts (GW) of power infrastructure, comprising 92 power packs of 25 megawatts (MW) each. Partnership with VoltaGrid drives the expansion of AI data centers through fast, flexible, and sustainable energy solutions. Collaboration enables VoltaGrid to seamlessly combine its power pack units with its large-scale portable data center power made up of INNIO’s units. INNIO Group today announced the largest order by power delivery in its history: a groundbreaking 2.3 GW power infrastructure project featuring 92 power packs, each delivering 25 MW of output. The initiative with VoltaGrid strengthens INNIO’s position as a key energy solutions provider for the rapidly expanding U.S. data center sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021503080/en/ INNIO Secures Largest Order in Company History (c) INNIO “This landmark order underscores the strength of INNIO’s technology and our ability to power
P.I. Works Celebrates 20 Years of Shaping the Telecom Industry21.10.2025 09:00:00 CEST | Press release
Empowering Operators Worldwide Through Innovation, Automation, and Solutions for Two Decades P.I. Works, the leading independent provider of AI-driven mobile network automation, optimization, and assurance solutions, proudly celebrates its 20th anniversary. This milestone marks two decades of driving telecom innovation and enabling mobile operators to deliver superior network performance, operational efficiency, and customer experience worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021105217/en/ P.I. Works Celebrates 20 Year Anniversary From Network Optimization to AI-Driven Automation Founded in 2005, as mobile data traffic surged with the rise of 3G, P.I. Works introduced intelligent solutions to help operators plan, manage, and optimize their networks more efficiently. Over the years, the company pioneered Self-Organizing Network (SON) capabilities, establishing the foundation for large-scale automation and
The Coca-Cola Company and Gutsche Family Investments Agree to Sell Controlling Interest in Coca-Cola Beverages Africa to Coca-Cola HBC AG21.10.2025 08:00:00 CEST | Press release
The Coca-Cola Company and Gutsche Family Investments have agreed to sell a 75% controlling interest in Coca-Cola Beverages Africa Pty. Ltd. to Coca-Cola HBC AG, the companies announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020939952/en/ CCBA is the largest Coca-Cola bottler in Africa. It operates in 14 countries on the continent and accounts for about 40% of all Coca-Cola product volume sold across Africa. Coca-Cola HBC is one of the largest Coca-Cola bottlers in the world, with operations in 29 countries across Europe and Africa, including Nigeria and Egypt. Coca-Cola will sell 41.52% out of its 66.52% stake in CCBA to Coca-Cola HBC, and Coca-Cola HBC is acquiring 33.48% of CCBA that is held by GFI. In total, the transaction values 100% of CCBA at an equity value of US$3.4 billion. The transactions are targeted to close by the end of 2026. Coca-Cola and Coca-Cola HBC have also agreed to a separate option
Baszucki Group Announces Six Recipients of the Metabolic Psychiatry Scholar Award for Emerging Scientific Leaders Advancing Mental Health Innovation21.10.2025 08:00:00 CEST | Press release
Six early-career scientists and clinicians will receive $150,000 each to conduct research on metabolic therapies for mental health Baszucki Group is proud to announce the six recipients of the first-ever Metabolic Psychiatry Scholar Award, a new initiative that supports exceptional early-career scientists and clinicians working to advance understanding of the connection between metabolic health and mental health. The award represents a significant step forward in growing the rapidly advancing field of metabolic psychiatry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020666940/en/ Baszucki Group 2025 Metabolic Psychiatry Scholar Award Recipients The six scholars will each receive up to $150,000 over 18 months for original research in metabolic psychiatry. The award program advances Baszucki Group’s mission to transform mental health outcomes through research at the intersection of metabolism, psychiatry, and neuroscienc
AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer21.10.2025 07:17:00 CEST | Press release
Results from the TheraPb Phase 1b dose escalation presented at ESMO 2025 show a promising therapeutic index for 212Pb-ADVC001 in patients with metastatic castration-resistant prostate cancer (mCRPC) No dose-limiting toxicities and no treatment-related serious adverse events observed Xerostomia predominantly Grade 1 80% PSA50 response at doses ≥ 160 MBq 100% objective response rate (ORR) in patients with RECIST-measurable lesions, including two complete responses (CRs) The data represent the first clinical trial results for a Lead-212 (212Pb)-based PSMA-targeted radioligand therapy and highlight the potential of 212Pb-ADVC001 to enhance therapeutic options for patients with prostate cancer Phase 2 expansion will evaluate 160 MBq and 200 MBq of 212Pb-ADVC001 using a randomized multi-dose-response design and adaptive dosing strategies to optimize clinical outcomes in three indications: mCRPC (chemo-naïve, and post-177Lu-PSMA) and hormone-sensitive prostate cancer (mHSPC) AdvanCell, a clin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom